Compare · DFTX vs NAII
DFTX vs NAII
Side-by-side comparison of Definium Therapeutics Inc. (DFTX) and Natural Alternatives International Inc. (NAII): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DFTX and NAII operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- DFTX is the larger of the two at $4.65B, about 312.8x NAII ($14.9M).
- Over the past year, DFTX is up 340.0% and NAII is down 35.0% - DFTX leads by 375.0 points.
- DFTX has hit the wire 7 times in the past 4 weeks while NAII has been quiet.
- DFTX has more recent analyst coverage (6 ratings vs 0 for NAII).
- Company
- Definium Therapeutics Inc.
- Natural Alternatives International Inc.
- Price
- $42.64-1.16%
- $2.17-4.63%
- Market cap
- $4.65B
- $14.9M
- 1M return
- -4.79%
- -13.75%
- 1Y return
- +340.04%
- -34.98%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 7
- 0
- Recent ratings
- 6
- 0
Natural Alternatives International Inc.
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Asia, and internationally. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.
Latest DFTX
- Wells Fargo initiated coverage on Definium Therapeutics with a new price target
- A Depression Drug Just Cleared a Key Hurdle Early, and the Market for New Mental Health Treatments Keeps Widening
- Definium Therapeutics Announces New Employee Inducement Grants
- Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time
- Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (GAD) Patient Impact and Neurobiology
- New Healthcare Claims Study Published in CNS Spectrums Finds High Rates of Treatment Switching, Discontinuation, and Prolonged Gaps in Care Among Patients with Generalized Anxiety Disorder (GAD)
- Definium Therapeutics Announces New Employee Inducement Grants
- Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
- Chief Legal Officer Sullivan Mark sold $585,750 worth of shares (13,008 units at $45.03) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 320,571 units (SEC Form 4) (withholding tax)
- Chief Medical Officer Karlin Daniel sold $451,876 worth of shares (10,035 units at $45.03) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 503,282 units (SEC Form 4) (withholding obligation)
Latest NAII
- SEC Form S-8 filed by Natural Alternatives International Inc.
- SEC Form 10-Q filed by Natural Alternatives International Inc.
- SEC Form NT 10-Q filed by Natural Alternatives International Inc.
- CarnoSyn® Brands Expands TriBsyn® Applications Across Beverage, Dairy, and Medical Nutrition
- Natural Alternatives International Inc. filed SEC Form 8-K: Leadership Update
- CarnoSyn® Brands Launches CarnoSyn® 4X, a Next-Generation Beta-Alanine for Sports Performance
- Natural Alternatives International Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SEC Form 4 filed by Natural Alternatives International Inc.
- SEC Form 4 filed by Natural Alternatives International Inc.
- President, COO, & Sec. Wolf Kenneth covered exercise/tax liability with 5,151 shares and was granted 15,000 shares, increasing direct ownership by 7% to 141,831 units (SEC Form 4)